Aldeyra Therapeutics, Inc. (ALDX)

Aldeyra Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	59.34	54.53	142.82	144.42	104.79	52.86
Short-Term Investments	15.96	46.62	-	29.88	-	-
Cash & Short-Term Investments	75.3	101.15	142.82	174.3	104.79	52.86
Cash Growth	3.51%	-29.18%	-18.06%	66.33%	98.25%	16.52%
Other Receivables	-	-	-	3.24	0.03	-
Receivables	-	-	-	3.24	125.03	25
Prepaid Expenses	1.03	0.71	0.52	0.87	0.53	0.41
Other Current Assets	1.13	2.21	4.46	2.61	2.4	4.79
Total Current Assets	77.46	104.07	147.81	181.02	232.75	83.06
Property, Plant & Equipment	0.34	0.27	0.52	0.27	0.38	0.29
Long-Term Deferred Charges	-	0.27	-	-	-	-
Total Assets	77.8	104.61	148.33	181.29	233.14	83.35
Accounts Payable	0.01	0.18	1.34	0.13	1.02	0.38
Accrued Expenses	7	12.12	5.54	14.07	10.52	5.63
Current Portion of Long-Term Debt	15.2	0.03	15.15	0.91	-	3.66
Current Portion of Leases	0.27	0.27	0.24	0.25	0.23	0.23
Current Unearned Revenue	6	6	-	-	-	-
Other Current Liabilities	-	-	-	-	-	2.5
Total Current Liabilities	28.48	18.6	22.26	15.36	11.77	12.41
Long-Term Debt	-	15	-	14.92	15.5	11.43
Long-Term Leases	0.07	-	0.27	-	0.13	-
Long-Term Unearned Revenue	-	-	6	-	-	-
Total Liabilities	28.56	33.6	28.53	30.28	27.4	23.84
Common Stock	0.06	0.06	0.06	0.06	0.06	0.04
Additional Paid-In Capital	526.68	521.02	513.99	507.77	500.37	296.39
Retained Earnings	-477.5	-450.11	-394.26	-356.72	-294.69	-236.92
Comprehensive Income & Other	0	0.04	-	-0.1	-	-
Shareholders' Equity	49.24	71	119.8	151.01	205.74	59.51
Total Liabilities & Equity	77.8	104.61	148.33	181.29	233.14	83.35
Total Debt	15.54	15.3	15.66	16.08	15.86	15.33
Net Cash (Debt)	59.75	85.85	127.17	158.22	88.93	37.53
Net Cash Growth	4.59%	-32.49%	-19.63%	77.91%	136.96%	22.61%
Net Cash Per Share	1.00	1.44	2.16	2.71	1.65	1.10
Filing Date Shares Outstanding	60.16	59.71	58.9	58.58	58.1	47.25
Total Common Shares Outstanding	60.16	59.65	59.2	58.56	58.08	38.67
Working Capital	48.98	85.47	125.55	165.66	220.98	70.65
Book Value Per Share	0.82	1.19	2.02	2.58	3.54	1.54
Tangible Book Value	49.24	71	119.8	151.01	205.74	59.51
Tangible Book Value Per Share	0.82	1.19	2.02	2.58	3.54	1.54

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q